Wolfer, A.

Centre Hospitalier Universitaire Vaudois · University of Lausanne

1 paper on CoChatORCID 0000-0002-7109-2286

Most cited papers

Verified
An open-label, phase II basket study of olaparib and durvalumab (MEDIOLA): Results in germline BRCA -mutated ( gBRCA m) platinum-sensitive relapsed (PSR) ovarian cancer (OC)
Drew, Y., de Jonge, M., Hong, S. H., Park, Y. H., Wolfer, A., Brown, J., Ferguson, M., Gore, M. E., Alvarez, R. H., Gresty, C., et al. (2018) · Gynecologic Oncology
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 131

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free